The effect of taking Osimertinib for 8 years

Osimertinib (Osimertinib) is an oral drug commonly used to treat non-small cell lung cancer related to EGFR gene mutations. However, based on current clinical data and guidelines, there are no clear conclusions regarding long-term treatment with osimertinib. As a third-generation targeted drug, osimertinib is usually used when patients develop drug resistance or cannot tolerate other treatments. Most clinical trials tend to have shorter observation periods.

OsimertinibShows benefit in patients with resectable non-small cell lung cancerEGFR mutations are not associated with receipt of adjuvant chemotherapy. , for patients who receive osimertinib as second-line or second-line treatment for T790-positive non-small cell lung cancer, there may be triple mutations of EGFR 1858 r/T790M/C797S or EGFR xon19 del/T790M/C797S genotype. Some studies have shown that a significant proportion of patients treated with osimertinib can achieve long-term and effective control of tumor growth. This means that if patients are able to tolerate and benefit from treatment with osimertinib, they may continue to achieve long-term treatment benefits.

OsimertinibThe original drug has been launched in China and has entered the scope of medical insurance. Its name is Osimertinib Mesylate Tablets. The reimbursement ratio is different in different regions, and the price after reimbursement may be different. SpecificationThe price of 80mg*30 tablets per box is around RMB 5,000, which is relatively expensive. The original drug of Osimertinib has also been launched overseas, and there are also generics of Osimertinib produced in other countries. For example, the price of 80mg*30 tablets per box produced by Bangladesh Yaopin International is around RMB 850 (the price may fluctuate due to the exchange rate). The price is relatively cheap. The ingredients of the generic Osimertinib and the original drug are basically the same.